PSA Density Calculator

Calculate PSA density to help differentiate between prostate cancer and benign prostatic hyperplasia

Calculate PSA Density

ng/mL

Prostate-specific antigen level from blood test

mL

From mpMRI or transrectal ultrasound (TRUS)

PSA Density Results

0.000
ng/mL² PSA Density
0.0 mL
Prostate Volume

Formula: PSA Density = PSA Level (ng/mL) / Prostate Volume (mL)

Threshold: ≥0.15 ng/mL² suggests suspicion of prostate cancer

⚠️ Medical Disclaimer: This calculator is for educational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare provider for proper diagnosis and treatment decisions.

PSA Density Interpretation

< 0.10 ng/mL²: Generally considered low risk for prostate cancer

0.10-0.14 ng/mL²: Intermediate risk, requires clinical correlation

≥ 0.15 ng/mL²: Elevated risk, consider biopsy evaluation

Example Calculation

Clinical Scenario

Patient: 65-year-old male with elevated PSA

PSA Level: 6.8 ng/mL

Prostate Volume (TRUS): 45.2 mL

Calculation

PSA Density = PSA Level / Prostate Volume

PSA Density = 6.8 ng/mL ÷ 45.2 mL

PSA Density = 0.150 ng/mL²

Result: At threshold value - warrants urological consultation

About PSA

What is PSA?

Prostate-Specific Antigen (PSA) is a protein produced by prostate cells. Elevated levels may indicate prostate cancer, BPH, or prostatitis.

Normal PSA Levels

  • • Ages 40-49: < 2.5 ng/mL
  • • Ages 50-59: < 3.5 ng/mL
  • • Ages 60-69: < 4.5 ng/mL
  • • Ages 70+: < 6.5 ng/mL

Prostate Cancer Risk Factors

Age (>50 years)

Family history

African American ethnicity

Genetic mutations (BRCA1/2)

Clinical Tips

PSA density helps differentiate cancer from BPH in mildly elevated PSA cases

Consider age, family history, and digital rectal exam findings

Low PSA density doesn't completely exclude prostate cancer

Understanding PSA Density

What is PSA Density?

PSA density is a calculation that divides the PSA level by the prostate volume. It helps distinguish between prostate cancer and benign prostatic hyperplasia (BPH) in patients with mildly elevated PSA levels.

Clinical Significance

  • Helps determine need for prostate biopsy
  • Improves specificity of PSA testing
  • Reduces unnecessary biopsies in BPH cases
  • Assists in risk stratification

Measurement Methods

Multiparametric MRI (mpMRI)

Most accurate method for prostate volume measurement. Provides detailed imaging of prostate anatomy and can detect suspicious lesions.

Transrectal Ultrasound (TRUS)

Commonly used method that measures prostate dimensions. Uses formula: Volume = (L × W × H × π) / 6

Important: Volume measurements may vary between methods. Clinical correlation is essential.

Important Medical Considerations

Limitations of PSA Density

  • • Cannot definitively exclude prostate cancer
  • • Affected by measurement accuracy
  • • Age and ethnicity considerations needed
  • • Should be interpreted with other factors

When to Consult a Urologist

  • • PSA density ≥ 0.15 ng/mL²
  • • Abnormal digital rectal exam
  • • Strong family history of prostate cancer
  • • Persistent PSA elevation